Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ESR2 | hg19_v2_chr14_-_64804814_64804842 | -0.28 | 1.2e-01 | Click! |
ESRRA | hg19_v2_chr11_+_64073022_64073056 | 0.24 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106174960 Show fit | 10.28 |
ENST00000390547.2
|
immunoglobulin heavy constant alpha 1 |
|
chr1_-_173886491 Show fit | 9.71 |
ENST00000367698.3
|
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
chr10_-_54531406 Show fit | 7.76 |
ENST00000373968.3
|
mannose-binding lectin (protein C) 2, soluble |
|
chr22_+_22676808 Show fit | 7.64 |
ENST00000390290.2
|
immunoglobulin lambda variable 1-51 |
|
chr9_-_116840728 Show fit | 7.44 |
ENST00000265132.3
|
alpha-1-microglobulin/bikunin precursor |
|
chr22_+_23248512 Show fit | 7.01 |
ENST00000390325.2
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
|
chr14_-_106322288 Show fit | 6.92 |
ENST00000390559.2
|
immunoglobulin heavy constant mu |
|
chr22_+_23237555 Show fit | 6.83 |
ENST00000390321.2
|
immunoglobulin lambda constant 1 (Mcg marker) |
|
chr14_-_106054659 Show fit | 6.76 |
ENST00000390539.2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
|
chr17_-_7082861 Show fit | 6.58 |
ENST00000269299.3
|
asialoglycoprotein receptor 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 105.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.9 | 95.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 88.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 86.2 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 76.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.6 | 36.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.4 | 35.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.9 | 32.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.4 | 26.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.2 | 24.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 105.9 | GO:0072562 | blood microparticle(GO:0072562) |
2.0 | 103.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 44.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 42.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.4 | 40.4 | GO:0035580 | specific granule lumen(GO:0035580) |
0.4 | 40.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 36.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 35.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 33.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 29.2 | GO:0016605 | PML body(GO:0016605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 200.5 | GO:0003823 | antigen binding(GO:0003823) |
1.9 | 123.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 54.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 44.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 34.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 25.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 21.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.6 | 21.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 19.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
2.0 | 17.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 63.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.8 | 58.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 42.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 34.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 29.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 29.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 27.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 24.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 23.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 21.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 96.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.7 | 36.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.4 | 36.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.1 | 33.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 31.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 29.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 28.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 26.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.4 | 25.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.8 | 23.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |